Evidence map›Paper›PMID 33015653›Full record

ArticleThe Lancet. Microbe2020

Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study.

Bernadette Schurink, Eva Roos, Teodora Radonic, Ellis Barbe, Catherine S C Bouman, Hans H de Boer, Godelieve J de Bree, Esther B Bulle, Eleonora M Aronica, Sandrine Florquin and 20 more

Open access · goldAbstract read
In one paragraph

Article in The Lancet. Microbe, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 341 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
341citing papers in PubMed, 6 pooled it
11.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

341 citing papers in PubMed, 6 syntheses or guidelines pooled it, 555 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. COVID-19-Associated cardiac pathology at the postmortem evaluation: a collaborative systematic review.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2022
    Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Human brain matters: Navigating the neuropathology of COVID-19.Brain pathology (Zurich, Switzerland) · 2026
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. A survey of SARS-CoV-2 tropism.Infectious diseases & immunity · 2025
    Review
  16. Review
  17. Article
  18. Article
  19. SARS-CoV-2 N protein induces hypokalemia in acute kidney injury mice via ENaC-dependent mechanism.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Article
  20. Review

281 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

30 authors at 4 institutions in 1 country.

Bernadette SchurinkDepartment of Pathology, Amsterdam University Medical Centers (UMC), VU University Amsterdam, Amsterdam, Netherlands.
Eva RoosDepartment of Pathology, Amsterdam University Medical Centers (UMC), VU University Amsterdam, Amsterdam, Netherlands.
Teodora RadonicDepartment of Pathology, Amsterdam University Medical Centers (UMC), VU University Amsterdam, Amsterdam, Netherlands.
Ellis BarbeDepartment of Pathology, Amsterdam University Medical Centers (UMC), VU University Amsterdam, Amsterdam, Netherlands.
Catherine S C BoumanDepartment of Intensive Care Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Hans H de BoerDepartment of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Godelieve J de BreeDepartment of Internal Medicine, Amsterdam Infection and Immunity Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Esther B BulleDepartment of Intensive Care Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Eleonora M AronicaDepartment of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Sandrine FlorquinDepartment of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Judith FronczekDepartment of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Leo M A HeunksDepartment of Intensive Care Medicine, Amsterdam University Medical Centers (UMC), VU University Amsterdam, Amsterdam, Netherlands.
Menno D de JongDepartment of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Lihui GuoDepartment of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Romy du LongDepartment of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Rene LutterDepartment of Pulmonary Diseases, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Pam C G MolenaarDepartment of Pulmonary Diseases, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
E Andra Neefjes-BorstDepartment of Pathology, Amsterdam University Medical Centers (UMC), VU University Amsterdam, Amsterdam, Netherlands.
Hans W M NiessenDepartment of Pathology, Amsterdam University Medical Centers (UMC), VU University Amsterdam, Amsterdam, Netherlands.
Carel J M van NoeselDepartment of Pathology, Amsterdam University Medical Centers (UMC), VU University Amsterdam, Amsterdam, Netherlands.
Joris J T H RoelofsDepartment of Pathology, Amsterdam University Medical Centers (UMC), VU University Amsterdam, Amsterdam, Netherlands.
Eric J SnijderMolecular Virology Laboratory, Department of Medical Microbiology, Leiden University Medical Center, Leiden, Netherlands.
Eline C SoerDepartment of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Joanne VerheijDepartment of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Alexander P J VlaarDepartment of Intensive Care Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Wim VosDepartment of Pathology, Amsterdam University Medical Centers (UMC), VU University Amsterdam, Amsterdam, Netherlands.
Nicole N van der WelElectron Microscopy Center Amsterdam, Department of Medical Biology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Allard C van der WalDepartment of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Paul van der ValkDepartment of Pathology, Amsterdam University Medical Centers (UMC), VU University Amsterdam, Amsterdam, Netherlands.
Marianna BugianiDepartment of Pathology, Amsterdam University Medical Centers (UMC), VU University Amsterdam, Amsterdam, Netherlands.
Amsterdam University Medical Centers · NLUniversity of Amsterdam · NLLeiden University Medical Center · NLNetherlands Forensic Institute · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) targets multiple organs and causes severe coagulopathy. Histopathological organ changes might not only be attributable to a direct virus-induced effect, but also the immune response. The aims of this study were to assess the duration of viral presence, identify the extent of inflammatory response, and investigate the underlying cause of coagulopathy.

methodsThis prospective autopsy cohort study was done at Amsterdam University Medical Centers (UMC), the Netherlands. With informed consent from relatives, full body autopsy was done on 21 patients with COVID-19 for whom autopsy was requested between March 9 and May 18, 2020. In addition to histopathological evaluation of organ damage, the presence of SARS-CoV-2 nucleocapsid protein and the composition of the immune infiltrate and thrombi were assessed, and all were linked to disease course.

findingsOur cohort (n=21) included 16 (76%) men, and median age was 68 years (range 41-78). Median disease course (time from onset of symptoms to death) was 22 days (range 5-44 days). In 11 patients tested for SARS-CoV-2 tropism, SARS-CoV-2 infected cells were present in multiple organs, most abundantly in the lungs, but presence in the lungs became sporadic with increased disease course. Other SARS-CoV-2-positive organs included the upper respiratory tract, heart, kidneys, and gastrointestinal tract. In histological analyses of organs (sampled from nine to 21 patients per organ), an extensive inflammatory response was present in the lungs, heart, liver, kidneys, and brain. In the brain, extensive inflammation was seen in the olfactory bulbs and medulla oblongata. Thrombi and neutrophilic plugs were present in the lungs, heart, kidneys, liver, spleen, and brain and were most frequently observed late in the disease course (15 patients with thrombi, median disease course 22 days [5-44]; ten patients with neutrophilic plugs, 21 days [5-44]). Neutrophilic plugs were observed in two forms: solely composed of neutrophils with neutrophil extracellular traps (NETs), or as aggregates of NETs and platelets..

interpretationIn patients with lethal COVID-19, an extensive systemic inflammatory response was present, with a continued presence of neutrophils and NETs. However, SARS-CoV-2-infected cells were only sporadically present at late stages of COVID-19. This suggests a maladaptive immune response and substantiates the evidence for immunomodulation as a target in the treatment of severe COVID-19.

fundingAmsterdam UMC Corona Research Fund.

Indexed as

Blood Coagulation DisordersCOVID-19ThrombosisAdultAgedAutopsyCohort StudiesFemaleHumansMaleMiddle AgedProspective StudiesSARS-CoV-2

Identifiers

PMID33015653
PMCPMC7518879
OpenAlexW3088800697

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.